ConductScience.org, home

Trial · NCT04712669

Participant flow48

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Open Label PhaseNOT COMPLETEDRodatristat Ethyl 300 mg BID0
Open Label PhaseNOT COMPLETEDRodatristat Ethyl 600 mg BID0
Open Label PhaseNOT COMPLETEDPlacebo0
Open Label PhaseNOT COMPLETEDPlacebo-Rodatristat Ethyl 300 mg15
Open Label PhaseNOT COMPLETEDPlacebo-Rodatristat Ethyl 600 mg16
Open Label PhaseNOT COMPLETEDRodatristat Ethyl 300 Mg-Rodatristat Ethyl 300 mg22
Open Label PhaseNOT COMPLETEDRodatristat Ethyl 300 Mg-Rodatristat Ethyl 600 mg2
Open Label PhaseNOT COMPLETEDRodatristat Ethyl 600 Mg-Rodatristat Ethyl 600 mg21

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04712669/flow?page=3